contact us
JW Therapeutics has filed the paperwork (PDF) for a Hong Kong IPO. The Juno Therapeutics-WuXi AppTech joint venture is seeking money to advance a cell therapy pipeline led by anti-CD19 CAR-T JWCAR029.
Do Not Allow Advertisers to Use My Personal information